SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IPIC
IPIC 0.00010000.0%Dec 18 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Haolin Ni who wrote (645)9/17/1997 11:02:00 AM
From: sds   of 1359
 
Where's the hope? Try looking at the pipeline!

This is a company with a very deep pipeline. A while back I said that IPIC should consider writing off Redux -- turns out I was right. Citicoline has been filed and is awaiting final approval. This stock will be a blockbuster and could contribute in '98. Secondly, Bucindolol is doing well and could be approved next year and marketed in '99. Pagoclone could be on the market in 2000 or 2001. Not to mention the nutrition side of the business (which I think is being marketed especially poorly...) and any "gravy" that comes out of Progenitor or TransCell.

While I'm not going to go into my calculations here, IPIC is worth about $12/share with CITICOLINE ONLY! Add Bucindolol and Pagoclone and you have a range of $16-36. The variation in the range is caused by changing the assumptions of a) liklihood of approval and b) market penetration assuming approval.

While I'm no longer holding IPIC stock, saying they are only worth $12/share or that they have no prospects is short-sighted and completely ignorant. On the basis of Citicoline alone, this stock/company could do extraordinarily well. Add to that the fact that there is a real lack of an adequate treatment for panic disorder and there is even more potential...

sds
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext